NCT00799552

Safety and Efficacy Study of RX-10045 on the Signs and Symptoms of Dry Eye

A Phase II, Multi-Center, Double-Masked, Randomized, Placebo Controlled, Study on the Safety and Efficacy of RX-10045 on the Signs and Symptoms of Dry Eye in Every Day Environmental Conditions and During Provocation Using the Controlled Adverse Environment (CAE) Model

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 232 (actual)
• Sponsor: Resolvyx Pharmaceuticals, Inc · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to compare the safety and efficacy of RX-10045 to placebo for the treatment of the signs and symptoms of dry eye.

Conditions

• Dry Eye Syndrome

Interventions

Type	Name	Description
DRUG	RX-10045	RX-10045 eye drop
DRUG	Placebo	Placebo eye drop

Timeline

• Start date: 2008-11-01
• Primary completion: 2009-05-01
• Completion: 2009-06-01
• First posted: 2008-12-01
• Last updated: 2010-09-24

Locations

1 site across 1 country: United States